Chronic kidney disease (CKD) is a global health problem that affects around 11 to 13% of the world's population and more than 18% of European citizens. Characteristic syndromes of CKD during all stages of the disease are proteinuria and ongoing glomerular dysfunction caused by cellular damages at the glomerular filtration barrier. While some rare cases of the disease are correlated to genetic depositions the majority of cases are caused by diabetes, glomerulosclerosis, high blood pressure and glomerulonephritis. Thus, recapitulating the interplay of high blood pressure and changes at the glomerular filtration barrier in vitro seems an adequate way to mimic CKD. Here we present a microphysiological system of the glomerular filter that is capable to simulate high blood pressure at the glomerular filtration barrier in vitro. It consists of a closed loop microfluidic circuit with an integrated pneumatically driven heart like micro pump that constantly circulates the cell culture media at the blood site of the glomerular barrier. The ThinCert™ insert could be reversibly integrated into a holder system that ensures the correct position of the insert within the microfluidic circuit. By using different modulations of the integrated pneumatic micro pump different physiological and pathophysiological conditions e.g. hypertonic stress, like in CKD, could be applied. The influence of hypertonic conditions on the filtration above the barrier was studied by changes of TEER values and measurement of the flux of fluorescent labelled albumin through the cellular barrier. Figure 5: Albumin permeation (Palb) above the barrier within 24 h at different pressure settings. Albumin permeation above the GFB (normalized to the surface area of 160 Nephrons/24-Well insert) in healthy individuals and in CKD patients are indicated by cyan and red lines.
Chronic kidney disease as glomerular dysfunction
Chronic kidney disease (CKD) is a global health problem that affects around 11 to 13% of the world's population and more than 18% of European citizens [1, 2] . While the 12-month incidence rates are moderate at just 0.17%, the main issue of CKD is the chronification throughout several stages leading to constant decline of patient's kidney function. At 4% of patients in stage III-V it results in permanent dysfunction and renal replacement therapy (RRT) (compare figure 1 ). This seems not just a problem of patient's health but also of health systems, caused by the high costs of RRT. CKD. Recent data force the hypothesis that proteinuria, that is highly associated to hypertension [3, 4] and Diabetes, is a major risk factor of CKD progression. Starting with endothelial damage at the glomerular filtration barrier (GFB) [5, 6] , what causes proteinuria, the disease exacerbates in later stages because tubular damage is triggered by glomerular dysfunction [7] . Recapitulating the interplay of high blood pressure and pathophysiological changes at the glomerular filtration barrier in vitro seems an adequate way to study the initial phase of CKD. Nevertheless most common artificial models of the glomerular barrier show good barrier functions but are lacking to emulate pressure derived effects on protein Transport across the barrier [8, 9] . Thus, we will show how microphysiological systems could be used to emulate such effects in vitro.
A microphysiological in vitro-

Glomerulus -the ZEBRA-Chip
To address the problem of Hypertension in vitro, the ZBBRA-Chip was designed (compare figure 2). It consists, like the human body, of a blood circuit that interconnects a heart like micro pump and a cell culture compartment for the integration of the artificial GFB. The chip is designed to integrate a 24-Well ThinCert™ cell culture Insert that contains a pre cultured artificial GFB. In comparison to the glomerular surface area of a single nephron (~0.2 mm 2 ) [10] , the cell culture insert contains the area of around 160 glomeruli (33.6 mm 2 ). Thus the heart like micro pump is supporting the cell culture compartment with constant fluid flow at moderate flow rates (v̇) of about 1 µL*s -1 , what is the 160 fold of the estimated renal plasma flow into a single glomerulus. Nevertheless pressure at the GFB has to be calculated and maintained according to the in vivo environment. In general the pressure at the GFB is the superposition of different pressure sources at both sides of the barrier (see eq. 1):
Pcap -hydrodynamic pressure of the glomerular capillary Pbow -hydrodynamic pressure of Bowman´s space πcap -kolloidosmotic pressure of the glomerular capillary πbow -kolloidosmotic pressure of Bowman´s space While the capillary pressure inside the glomerulus is around 80 mbar, the contrariwise hydrodynamic pressure at Bowman´s space is about 20 mbar. In opposite to that colloid osmotic pressure at Bowman´s space is 33 mbar, while it is 0 mbar at the capillary side. The resulting effective filtration pressure (Peff) at the GFB in vivo is 27-30 mbar. In contrast to the in vivo situation cell culture media in general have no significant difference in colloid osmotic pressure, even not during or after filtration above the artificial GFB. Thus we added florescence labelled albumin at the capillary side of the artificial GFB to ensure adequate effective filtration pressure. Besides that the chip system was used to apply hydrodynamic pressure.
The cellular model of the glomerular Filter
The artificial GFB was formed by seeding human immortalized podocytes (PODO-TERT) onto the upper side and human blood outgrowth endothelial cells (BEOC) onto the opposite side of a ThinCert™ membrane with a pore diameter of 0.4 µm. After 2 hours of adherence cells were grown to confluence to form a closed barrier. To evaluate the barrier formation and ensure tight junctions between the endothelial cells, transepithelial electrical resistance (TEER) was measured daily and cells where observed by brightfield imaging. One day before the assay started, VEGF was added to the Well at a final concentration of 100 ng*mL -1 to support fenestration of the glomerular endothelium.
Assay setup
The Assay was dived into sub processes that are shown in figure 3 . It started with barrier formation, like described above. After 2-4 days TEER values reached 125 to 150 Ωcm² and the assay was started by plugging the inserts into the ZEBRA-chip and applying either physiological conditions (Peff=27 mbar) or pathophysiological conditions (Peff=47 mbar) , like they occur in CKD. Afterwards permeation through the barrier was studied by adding fluorescence labelled albumin (100 µg/mL). As negative control and comparison to recent studies, inserts were used in a microwell plate without applying pressure.
Barrier properties of the in vitro GFB
Barrier properties of the artificial GFB were estimated by different measurements. While the expression of specific endothelial adhesion molecules, like VE-Cadherin, as well as the TEER value of the artificial GFB, serves as indicator for the barrier integrity, the permeation of albumin above the membrane should demonstrate the filtration specific properties of the artificial GFB at different pressure regimes as they occur in health and disease.
Cell characterization and TEER
Adherens junctions (AJs) serve as mediator for the tissue specific permeability of endothelial cells by forming zipper like clusters composed of VE-Cadherin molecules [11] . Thus the fluorescence staining of VE-Cadherin, like it is shown in the left column of figure 4 , indicates the outer border of endothelial cells within a closed monolayer and gives a hint on barrier integrity. The staining shows closed layers for pressure conditions of 0 and 27 mbar. In opposite to that the application of an effective pressure of 47 mbar for two days decreases AJs. This thesis is supported by Live/Dead staining that showed an increase in dead cells at 47 mbar (figure 4 right column). Also TEER-values that were measured before and after the application of pressure showed similar results. Whereas TEER was decreased after VEGF administration by 15 Ωcm² it remained stable at around 100 Ωcm² at a pressure of 0 and 27 mbar. In contrast to that TEER was reduced to 63 Ωcm² at 47 mbar. 
Albumin permeation in vitro
To investigate whether the changes in barrier integrity are correlating with increased transport above, the permeation of fluorescent labelled albumin was measured as shown in figure 5 . It shows that permeation without any pressure is at 1.9 µg*33.6 mm -²*24 h, what is reduced by factor 0.5 compared to other studies [12] . Nevertheless these studies used BSA instead of Albumin and different inserts, regarding pore density and surface area. When pressure is applied, permeation is increasing moderate (1.7 fold) if physiological pressure (27 mbar) is applied, but dramatically (6.9 fold) if pathophysiological pressure (47mbar) is set. This is in accordance to the results acquired by VE-Cadherin and Live/Dead staining. Compared to the normalized albumin permeation in healthy people (cyan line) [13] , the in vitro permeation at 27 mbar shows best accordance (M(27mbar)=3,3; M(healthy people)=4), while permeation at 47 mbar is close to CKD like Proteinuria (red line).
Conclusion
This study shows that basic permeation properties of the GFB, including pressure dependent increase of substance transport, can be mimicked in vitro. CKD like conditions increase the permeability of the artificial GFB and lead to cellular damage. Nevertheless further studies have to prove whether barrier integrity could be maintained for 7 or 21 days to investigate long term effects in vitro.
